pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,772 catalysts · 6,459 phase readout · 2,307 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 17 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,459
  • 8k filing2,307
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05638880: Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

Sponsor: Mostafa Bahaa. Phase: PHASE2. Conditions: Diabetic Nephropathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT07259096: Comparison of Sports Anxiety, Sports Injury Anxiety, and Knowledge Levels Regarding Factors Causing Sports Injury in Individuals Who Regularly Engage in Conditioning Work With and Without a History of Injury

Sponsor: Istanbul Saglik Bilimleri University. Phase: . Conditions: People Who Do Regular Conditioning Work

full page →ctgov ↗
›RECRUITINGphase readoutNCT05081596: A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Depression, Pain, Cognitive Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07693296: Type 2 Diabetes Mellitus and Downhill Aerobic Exercise Training

Sponsor: Acibadem University. Phase: NA. Conditions: Diabete Type 2, Aerobic Exercise, Walking

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07147582: Effect of Transcranial Alternating Current Stimulation on Sleep Disorder and Anxiety in Elderly Population

Sponsor: Cairo University. Phase: NA. Conditions: Chronic Sleep Disorders, Anxiety Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06564324: A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients

Sponsor: Nuvation Bio Inc.. Phase: PHASE3. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06483659: Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583459: Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

Sponsor: University of South Carolina. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07704359: Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess

Sponsor: University of Illinois at Chicago. Phase: PHASE4. Conditions: Perianal Abscess, Anal Fistula

full page →ctgov ↗
›COMPLETEDphase readoutNCT05384080: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

Sponsor: Takeda. Phase: . Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06336980: Creating Welcoming Faith Communities for People With Serious Mental Illnesses

Sponsor: Temple University. Phase: NA. Conditions: Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT04993079: Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure

Sponsor: Sensome. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07539779: Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Sponsor: Nanfang Hospital, Southern Medical University. Phase: PHASE2. Conditions: Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies, Myelofibrosis (MF)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04939896: Study on the Trajectories of Rehabilitation Compliance in Stroke Patients

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Stroke, Acute

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07670962: Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

Sponsor: Asan Medical Center. Phase: . Conditions: Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Ovarian Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07702396: Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Sponsor: Indus Hospital and Health Network. Phase: NA. Conditions: Heptatitis C

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07537413: Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

Sponsor: University of Maryland, Baltimore. Phase: PHASE4. Conditions: Community Acquired Pneumonia (CAP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05453513: The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV

Sponsor: University of Miami. Phase: NA. Conditions: Depression, Cannabis Use Disorder, HIV

full page →ctgov ↗
›TERMINATEDphase readoutNCT05815160: Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy

Sponsor: Debiopharm International SA. Phase: PHASE1. Conditions: Small Cell Lung Cancer Recurrent

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01154920: Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524920: Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria

Sponsor: Ain Shams University. Phase: PHASE2. Conditions: MDR Bacteria

full page →ctgov ↗
›COMPLETEDphase readoutNCT03052920: Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗
›RECRUITINGphase readoutNCT07251582: Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Sponsor: Hunan Province Tumor Hospital. Phase: PHASE3. Conditions: Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07610382: Balanced Crystalloid vs Normal Saline in Pediatric Acute Gastroenteritis

Sponsor: Aydin Adnan Menderes University. Phase: . Conditions: Gastroenteritis Acute, Dehydration, Acidosis, Metabolic, Diarrhea, Vomiting

full page →ctgov ↗
›RECRUITINGphase readoutNCT07644624: Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)

Sponsor: Hospital Universitari de Bellvitge. Phase: NA. Conditions: Anterior Shoulder Instability, Shoulder Instability, Shoulder Dislocation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03495882: A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

Sponsor: Agenus Inc.. Phase: PHASE1. Conditions: Cervical Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07677124: AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images

Sponsor: Istanbul Training and Research Hospital. Phase: . Conditions: Basal Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07319624: Bedside PEEP Selection in by Electrical Impedence Tomography During Mechanical Ventilation in Children

Sponsor: Papa Giovanni XXIII Hospital. Phase: NA. Conditions: Pneumonia, Tetralogy of Fallot Correction, Caustics Ingestion, Orthotopic Liver Transplantation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06857123: Feasibility of Resting Intervals During Exercise Programs for Individuals With Knee Osteoarthritis

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Knee Osteoarthristis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01439659: Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Ovarian Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06229080: Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization

Sponsor: Next Biomedical Co., Ltd.. Phase: NA. Conditions: Liver Cancer (Primary and Metastatic)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07256379: Influence of Two Different Occlusal Schemes Following Single Molar Implant-supported Restorations.

Sponsor: International Dental Contiuing Education. Phase: NA. Conditions: Implant Occlusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT01990079: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD

Sponsor: Duke University. Phase: NA. Conditions: PTSD, Smoking

full page →ctgov ↗
›RECRUITINGphase readoutNCT07074496: Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Sponsor: The First Affiliated Hospital of Soochow University. Phase: EARLY_PHASE1. Conditions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07494162: Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome

Sponsor: University of California, Davis. Phase: NA. Conditions: Myofascial Pain Syndrome (MPS), Chronic Low-back Pain (cLBP)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05818462: Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors

Sponsor: University of Colorado, Denver. Phase: . Conditions: Cancer, Childhood Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07052110: DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07703813: Energy Expenditure and Nutrition After Pancreatic Surgery

Sponsor: Evangelismos Hospital. Phase: . Conditions: Whipple Procedures, Pancreatic Cancer, Pancreaticoduodenectomy, Pancreatic Neoplasms

full page →ctgov ↗
›WITHDRAWNphase readoutNCT02467413: BAC in Patient With Alzheimer's Disease or Vascular Dementia

Sponsor: Botanicure Co., Ltd.. Phase: PHASE2. Conditions: Alzheimer's Disease, Vascular Dementia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05864560: Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.. Phase: . Conditions: Abdominal Aortic Aneurysm

full page →ctgov ↗
›TERMINATEDphase readoutNCT03996460: K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Sponsor: Georgetown University. Phase: PHASE2. Conditions: Dementia With Lewy Bodies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07249320: Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Sponsor: Pfizer. Phase: . Conditions: Respiratory Syncytial Virus (RSV)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06715020: Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

Sponsor: Peking University Cancer Hospital & Institute. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04055220: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07653620: Hydration & Female Life Stages

Sponsor: PepsiCo Global R&D. Phase: NA. Conditions: Dehydration, Menstruation, Pre-menopause, Peri-menopausal Women, Post-menopausal Women, Hydration

full page →ctgov ↗
›COMPLETEDphase readoutNCT06516120: Kinematics of Movements Provoked by an Augmented Reality App

Sponsor: Sint Maartenskliniek. Phase: . Conditions: Stroke, Healthy Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT05254782: Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Sponsor: University Health Network, Toronto. Phase: . Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05133882: A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Sponsor: Sunshine Lake Pharma Co., Ltd.. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07639710: Effect of Progressive Muscle Relaxation and Diaphragmatic Breathing on Sleep Disturbances in Chemotherapy Patients

Sponsor: Cairo University. Phase: NA. Conditions: Sleep Disturbance, Sleep Disorders, Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05995613: Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color

Sponsor: University of North Carolina, Chapel Hill. Phase: . Conditions: Oxygen Saturation

full page →ctgov ↗
← prev
page 175 of 176
next →